Market closed
Jaguar Health/$JAGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jaguar Health
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Ticker
$JAGX
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
49
Website
Jaguar Health Metrics
BasicAdvanced
$7.4M
-
-$130.69
1.11
-
Price and volume
Market cap
$7.4M
Beta
1.11
52-week high
$15.48
52-week low
$4.02
Average daily volume
185K
Financial strength
Current ratio
1.634
Quick ratio
0.49
Long term debt to equity
269.395
Total debt to equity
406.794
Interest coverage (TTM)
-133.47%
Management effectiveness
Return on assets (TTM)
-36.99%
Return on equity (TTM)
-565.74%
Valuation
Price to revenue (TTM)
0.277
Price to book
0.8
Price to tangible book (TTM)
-0.52
Price to free cash flow (TTM)
-0.109
Growth
Revenue change (TTM)
19.75%
Earnings per share change (TTM)
-95.12%
3-year revenue growth (CAGR)
39.19%
Jaguar Health News
AllArticlesVideos
Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Accesswire·15 hours ago
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
Accesswire·2 days ago
Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients
Accesswire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Jaguar Health stock?
Jaguar Health (JAGX) has a market cap of $7.4M as of May 09, 2025.
What is the P/E ratio for Jaguar Health stock?
The price to earnings (P/E) ratio for Jaguar Health (JAGX) stock is 0 as of May 09, 2025.
Does Jaguar Health stock pay dividends?
No, Jaguar Health (JAGX) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Jaguar Health dividend payment date?
Jaguar Health (JAGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Jaguar Health?
Jaguar Health (JAGX) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.